Document is current

Any future updates will be listed below

Selektiver IL-23-Inhibitor auch bei Colitis ulcerosa zugelassen

Crossref DOI link: https://doi.org/10.1007/s15036-024-3801-x

Published Online: 2024-12-12

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark